Bastide Le Confort MedicalLTS:0IP1 -2.32%71 EV-to-FCF is 7.92 as of Jul. 01, 2026, which is 66% below its 10-year median of 23.02. GuruFocus rates LTS:0IP1 with a GF Score™ of 71/100 and a GF Value™ of €25.96 (Fairly Valued). The stock has 2 warning signs investors should review. Among 75 Medical Distribution companies, Bastide Le Confort Medical ranks better than 78.67% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bastide Le Confort Medical's Enterprise Value is €470.8 Mil.
Bastide Le Confort Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €59.4 Mil. Therefore, Bastide Le Confort Medical's EV-to-FCF for today is 7.92.
The historical rank and industry rank for Bastide Le Confort Medical's EV-to-FCF or its related term are showing as below:
LTS:0IP1'
s EV-to-FCF Range Over the Past 10 Years
Min: -1009.89 Med: 23.02 Max: 189.66
Current: 8.08
During the past 13 years, the highest EV-to-FCF of Bastide Le Confort Medical was 189.66. The lowest was -1009.89. And the median was 23.02.
LTS:0IP1's EV-to-FCF is ranked better than 78.67% of 75
companies
in the Medical Distribution industry
Industry Median: 16.81
vs LTS:0IP1: 8.08
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bastide Le Confort Medical (LTS:0IP1) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bastide Le Confort Medical's PE Ratio (TTM) for today is calculated as:
Bastide Le Confort Medical's share price for today is €24.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bastide Le Confort Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €3.710.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Bastide Le Confort Medical EV-to-FCF Related Terms
Bastide Le Confort Medical EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Bastide Le Confort Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bastide Le Confort Medical EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Bastide Le Confort Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Bastide Le Confort Medical's EV-to-FCF falls into.
Bastide Le Confort Medical's current Enterprise Value is €470.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bastide Le Confort Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €59.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bastide Le Confort Medical (LTS:0IP1) has a EV-to-FCF of 7.92 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bastide Le Confort Medical and its competitors. This is 66% below median its historical median of 23.02. According to the industry distribution chart, Bastide Le Confort Medical ranks #16 out of 75 companies in the Medical Distribution industry, placing it in the top 21.3%.
Is Bastide Le Confort Medical's EV-to-FCF too high?
Bastide Le Confort Medical's current EV-to-FCF of 7.92 is 66% below median its 10-year median of 23.02. The Medical Distribution industry median EV-to-FCF is 16.81. Bastide Le Confort Medical's value of 7.92 is 52.9% below this industry median. Based on the distribution chart, Bastide Le Confort Medical ranks #16 out of 75 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Bastide Le Confort Medical has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Bastide Le Confort Medical ranks #16 out of 75 companies for EV-to-FCF. This places Bastide Le Confort Medical in the top 21% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 16.81. Bastide Le Confort Medical's value of 7.92 is 52.9% below this benchmark. While the company's 10-year median is 23.02 vs. the industry median of 16.81, Bastide Le Confort Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.81, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bastide Le Confort Medical's current EV-to-FCF of 7.92 is 52.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bastide Le Confort Medical and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bastide Le Confort Medical's current EV-to-FCF is 7.92, which is 66% below median its own 10-year median of 23.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (LTS:0IP1) is currently considered Fairly Valued. The stock's GF Value™ is €25.96, compared to a current price of €24.25 — trading 6.6% below its estimated fair value. The current EV-to-FCF is 7.92, which is 66% below median its 10-year median of 23.02 and 52.9% below the Medical Distribution industry median of 16.81. Bastide Le Confort Medical's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Bastide Le Confort Medical (LTS:0IP1), the current EV-to-FCF is 7.92 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bastide Le Confort Medical (LTS:0IP1) Overvalued in 2026?
Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued.
The current stock price of €24.25 is trading 6.6% below its estimated GF Value™ of €25.96.
GuruFocus considers Bastide Le Confort Medical to be Fairly Valued.
Key valuation signals for LTS:0IP1:
EV-to-FCF: 7.92 (66% below median its 10-year median of 23.02)
GF Value™: €25.96 vs. price of €24.25 (6.6% below fair value)
Industry Position: 52.9% below the Medical Distribution median (#16 of 75)
No single metric tells the full story. See the LTS:0IP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
71GF Score
Get the complete analysis for LTS:0IP1
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0IP1 has been successfully added to your 
